John L. Higgins
Overview
John L. Higgins received an average of $4M in total compensation, including $537K in salary, at Ligand Pharmaceuticals from 2007 to 2021.
2021Ligand PharmaceuticalsChief Executive Officer
2020Ligand PharmaceuticalsChief Executive Officer
2019Ligand PharmaceuticalsChief Executive Officer
2018Ligand PharmaceuticalsChief Executive Officer
2017Ligand PharmaceuticalsChief Executive Officer
2016Ligand PharmaceuticalsChief Executive Officer
2015Ligand PharmaceuticalsChief Executive Officer
2014Ligand PharmaceuticalsChief Executive Officer
2013Ligand PharmaceuticalsPresident and Chief Executive Officer
2012Ligand PharmaceuticalsPresident and Chief Executive Officer
Source: SEC filings on April 22, 2022, November 12, 2020, April 24, 2020, April 30, 2018, April 14, 2017, April 12, 2016, March 12, 2015, April 21, 2014, April 25, 2013, and April 29, 2009.
Related executives
We found eight more executives who work or worked at Ligand Pharmaceuticals.
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
Charles Berkman
Ligand Pharmaceuticals
General Counsel
Nishan de Silva
Ligand Pharmaceuticals
Chief Financial Officer
Melanie Herman
Ligand Pharmaceuticals
Chief Financial Officer
John Sharp
Ligand Pharmaceuticals
Chief Financial Officer
Martin Meglasson
Ligand Pharmaceuticals
Vice President, Discovery Research
Zofia Dziewanowska
Ligand Pharmaceuticals